ClinicalTrials.gg
RecruitingNCT05793944Updated May 4, 2026

SmartMom: Teaching by Texting to Promote Health Behaviours in Pregnancy

An interventional study of SmartMom text messaging and Control text messaging in Pregnancy, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to female participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by University of British Columbia · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Nov 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
3,078
Allocation
Randomized
Ages
15 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 156 studies in Psychological Well-Being with a site in Canada — 45 open to participants now, 59 under way, 1 of them phase 3. Psychological Well-Being · Canada.

Planned enrollment
6th of 128
3,078 · median 100
Started
2023
with 17 others
No phase
120 of 156
35 open now
Primary completion
2026-12
later than 28 of 58 live
Registered
99th of 156
by date
Lead sponsor
7 of 156
University of British Columbia

Among the 156 studies in Psychological Well-Being with a site in Canada, this one is the 6th largest by planned enrollment of the 128 interventional ones that give a count, is one of 18 that started in 2023, is one of 120 with no phase, reaches primary completion later than 28 of the 58 other live ones, and was the 99th registered.

Psychological Well-Being

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

45 of the 156 studies in Psychological Well-Being with a site in Canada are open now. Recruiting first, the newest first:

39 more — sign in →

All 45 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.

This study: 15 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 156 studies in Psychological Well-Being with a site in Canada, or all of them as a file.
02

Study summary

The goal of this randomized clinical trial is to evaluate the effectiveness of SmartMom, a text messaging-based mobile health program for prenatal education. The main questions are to determine if healthy pregnant people receiving SmartMom messages that promote health behaviours in pregnancy versus messages that don't provoke behaviour change have improvement in:

  1. knowledge about healthy pregnancy and birth
  2. standardized measures of depression, anxiety, and fear of childbirth
  3. adoption of positive health behaviours in pregnancy
  4. maternal, fetal, and newborn outcomes

Participants in the intervention group will receive three evidence-based text messages per week, plus optional supplemental messages on topics relevant to them, throughout pregnancy.

The control group will receive general interest messages on pregnancy-related topics that are not promoting behaviour change.

03

Conditions studied

  • Pregnancy

Keywords

  • prenatal education
  • perinatal outcomes
  • text messaging
  • mobile health
  • mental health
  • health behaviour
04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • pregnant person
  • at 15 weeks gestation or earlier
  • singleton pregnancy
  • can read and understand English at grade 8 level and comfortable completing online surveys
  • live in Canada (excluding British Columbia where SmartMom has been piloted)

Exclusion criteria

Exclusion Criteria:

  • health conditions existing prior to pregnancy that require individualized care (e.g. hypertension, cardiac disease, diabetes)
  • previously had a baby with the SmartMom program
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,078 participants (estimated)

Study arms

  • Active comparator
    Intervention: SmartMom messaging

    Participants receive three text messages per week with evidence-based information to promote healthy behaviours during pregnancy.

    Behavioral: SmartMom text messaging

  • Placebo comparator
    Control messaging

    Participants receive one text message per week with general information about pregnancy but not about making healthy choices.

    Behavioral: Control text messaging

Interventions

  • BehavioralSmartMom text messaging

    SmartMom is a mobile health program delivered via text messaging that guides participants through each week of pregnancy. Participants receive three messages per week with links to content focused on improving knowledge, providing information about prenatal assessments and screening, and encouraging the adoption of behaviours to support healthy pregnancy and physiologic birth. Messages are consistent with current professional guidelines and peer reviewed prenatal education curricula. SmartMom provides optional supplemental streams for individuals who wish to have additional messages addressing topics such as reducing use of tobacco, alcohol or illicit drugs, depression, obesity, and maternal age over 35.

  • BehavioralControl text messaging

    Control arm participants will receive weekly text messages with accurate, general-interest information about pregnancy and about progress of the trial. Content is not geared to decision-making during pregnancy that may affect health outcomes.

06

What researchers measure

Primary outcomes

  1. Change in weight during pregnancy

    Rate of pregnancy weight gain in a range appropriate for pre-pregnancy BMI. These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.

    Time frame: Enrollment, 38 weeks gestation

  2. Attendance at prenatal care visits through pregnancy

    Rates of attendance at prenatal care appointments in adherence to Canadian guidelines. These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.

    Time frame: 38 weeks gestation

Secondary outcomes

  1. Changes in health knowledge through pregnancy

    Changes in health knowledge as measured by a 10-item knowledge test. Minimum score = 0, Maximum score = 10. Higher score indicates more knowledge i.e. more positive outcome.

    Time frame: Enrollment, 38 weeks gestation

  2. Health literacy at end of pregnancy

    Health literacy as measured by self-report of i) information-seeking from local health and social services resources; ii) awareness of their choices regarding serum genetic screening; iii) awareness of their choices to have (yes/no) serum glucose screening.

    Time frame: 38 weeks gestation

  3. Changes in fear of childbirth through pregnancy

    Changes in fear of childbirth as measured by The Childbirth Fear Scale, an 11-item, self-reported measure. Minimum score = 6, Maximum score = 66. Lower score means less fear, i.e. a more positive outcome.

    Time frame: Enrollment, 38 weeks gestational age

  4. Changes in depression through pregnancy

    Changes in depression as measured by the Edinburgh Postnatal Depression Scale. This is a 10-item, self-report screening tool for postnatal depression that is also valid for use during pregnancy. Minimum score = 0. zero, Maximum score = 30. Lower score means less depression, i.e. a more positive outcome.

    Time frame: Enrollment, 38 weeks gestational age

  5. Changes in anxiety through pregnancy

    Changes in anxiety as measured by the standardized 33-item Pregnancy Specific Anxiety Tool (PSAT). Minimum score = 6, Maximum score = 24. Lower score means less anxiety, i.e. a more positive outcome.

    Time frame: Enrollment, 38 weeks gestational age

  6. Changes in use of tobacco, vaping, alcohol, or cannabis through pregnancy among users.

    Among participants indicating that they are users of tobacco, vaping, alcohol, and/or cannabis at enrollment, change of use at the end of pregnancy will be measured by self-report. Report: proportion of users that stopped using per trial arm. Among users continuing to use: mean change in number of daily cigarettes, episodes of vaping, drinks per week, cannabis products per day or other specified use of recreational or prescription drugs used per day.

    Time frame: Enrollment, 38 weeks gestational age

  7. Rates of planned vaginal birth after cesarean

    Proportion of participants choosing to plan vaginal birth (VBAC) after a previous cesarean birth, among those deemed eligible by their caregivers. These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.

    Time frame: 38 weeks gestation

  8. Rates of exclusive breastfeeding at hospital discharge

    These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.

    Time frame: 1 month post birth

  9. Rates of adverse pregnancy outcomes as measured by gestational diabetes, stillbirth, preterm birth (<37 weeks gestation) and small for gestational age (SGA) status at birth.

    These include self-reported data as well as data from provincial prenatal registries and the Canadian Hospital Discharge Database linked via personal health number, provided as part of the consenting procedure.

    Time frame: 1 month post birth

  10. Incremental costs per incidence of suboptimal weight gain and inadequate prenatal care avoided.

    Incremental costs per incidence of suboptimal weight gain and inadequate prenatal care avoided for the intervention group when compared to control group as an incremental cost-effectiveness ratio.

    Time frame: Throughout pregnancy (up to 42 weeks) and birth, including hospital admission in which birth took place (up to 7 days).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Debessai Y, Costanian C, Roy M, El-Sayed M, Tamim H. Inadequate prenatal care use among Canadian mothers: findings from the Maternity Experiences Survey. J Perinatol. 2016 Jun;36(6):420-6. doi: 10.1038/jp.2015.218. Epub 2016 Jan 21. PubMed 26796126 ↗
  • Dzakpasu S, Fahey J, Kirby RS, Tough SC, Chalmers B, Heaman MI, Bartholomew S, Biringer A, Darling EK, Lee LS, McDonald SD. Contribution of prepregnancy body mass index and gestational weight gain to adverse neonatal outcomes: population attributable fractions for Canada. BMC Pregnancy Childbirth. 2015 Feb 5;15:21. doi: 10.1186/s12884-015-0452-0. PubMed 25652811 ↗
  • Ganer Herman H, Dekalo A, Jubran L, Schreiber L, Bar J, Kovo M. Obstetric outcomes and placental findings in gestational diabetes patients according to maternal prepregnancy weight and weight gain. J Matern Fetal Neonatal Med. 2019 May;32(10):1682-1687. doi: 10.1080/14767058.2017.1416078. Epub 2018 Feb 5. PubMed 29402158 ↗
  • Munro S, Hui A, Salmons V, Solomon C, Gemmell E, Torabi N, Janssen PA. SmartMom Text Messaging for Prenatal Education: A Qualitative Focus Group Study to Explore Canadian Women's Perceptions. JMIR Public Health Surveill. 2017 Feb 7;3(1):e7. doi: 10.2196/publichealth.6949. PubMed 28174149 ↗
  • van den Heuvel JF, Groenhof TK, Veerbeek JH, van Solinge WW, Lely AT, Franx A, Bekker MN. eHealth as the Next-Generation Perinatal Care: An Overview of the Literature. J Med Internet Res. 2018 Jun 5;20(6):e202. doi: 10.2196/jmir.9262. PubMed 29871855 ↗
  • Ennis M, Renner RM, Morando-Stokoe C, James S, Janssen PA, Leckie S, Dunn S, Mazza D, Norman WV. Exploring Methods to Mitigate Fraud in Web-Based Surveys: Multicase Study Analysis. J Med Internet Res. 2025 Dec 1;27:e78671. doi: 10.2196/78671. PubMed 41324984 ↗
  • Janssen P, Lecke S, Renner R, Zhang W, Vedam S, Norman WV, Bayrampour H, Tough S, Murray J, Muhajarine N, Dennis CL. Teaching by texting to promote positive health behaviours in pregnancy: a protocol for a randomised controlled trial of SmartMom. BMJ Open. 2024 Jan 18;14(1):e081730. doi: 10.1136/bmjopen-2023-081730. PubMed 38238058 ↗

Individual participant data

Plan to share: Yes — Individual participant data will be available from the corresponding author upon reasonable request including a research proposal outlining how the data will be used and a certificate of ethical approval from an academic ethics review board.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: At completion of study enrollment for five years

Access criteria: Available to academic researchers who have submitted a research protocol that has been approved by a university ethics board.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Dec 2026, 37 months after the start.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 37 months is above that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2023
First posted
Mar 31, 2023
StartActual
Nov 10, 2023
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jun 2027
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05793944
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Patricia Janssen (Professor, University of British Columbia) — Principal investigator
First posted
Mar 31, 2023
Start date
Nov 10, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
May 4, 2026

Study contacts

Sara Leckie, MSc
Contact
sara.leckie@ubc.ca
604-875-2345 ext. 5415
Patti Janssen, PhD
Contact
patti.janssen@ubc.ca
604-313-8243
Patti Janssen, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion